H.C. Wainwright analyst Vernon Bernardino downgraded Neovasc (NVCN) to Neutral from Buy with a price target of $27.75, up from $20, after Shockwave Medical (SWAV) agreed to acquire all of the issued and outstanding common shares of the company for $27.25 per share.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on NVCN: